Q BioMed Inc.
QBIO
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Net Income | -721.60K | 2.30M | -795.10K | -1.27M | -2.29M |
| Total Depreciation and Amortization | 12.50K | 12.50K | 12.50K | 12.50K | 12.50K |
| Total Amortization of Deferred Charges | 195.60K | 1.70K | 177.50K | 391.60K | 351.80K |
| Total Other Non-Cash Items | 16.20K | 63.30K | -67.00K | 394.40K | 878.30K |
| Change in Net Operating Assets | 359.10K | 287.60K | 432.80K | 362.30K | 669.10K |
| Cash from Operations | -138.20K | 2.67M | -239.30K | -110.00K | -376.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -3.14M | -- | -- | -- |
| Cash from Investing | -- | -3.14M | -- | -- | -- |
| Total Debt Issued | 111.40K | 302.70K | 350.00K | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 85.00K | 0.00 | 0.00 | 70.00K |
| Cash from Financing | 111.40K | 387.70K | 350.00K | 0.00 | 170.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -267.20K | -- | -- | -- | -- |
| Net Change in Cash | -294.00K | -87.90K | 110.70K | -110.00K | -206.80K |